tradingkey.logo

Lexaria Bioscience Corp <LEXX.OQ> expected to post a loss of 16 cents a share - Earnings Preview

ReutersJul 8, 2025 11:01 AM
  • Lexaria Bioscience Corp LEXX.OQ LEXX.O is expected to show a rise in quarterly revenue when it reports results on July 10 (estimated) for the period ending May 31 2025

  • The Kelowna British Columbia-based company is expected to report a 8.7% increase in revenue to $91.33 thousand from $84 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Lexaria Bioscience Corp is for a loss of 16 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Lexaria Bioscience Corp is $5.50, about 84.1% above its last closing price of $0.87

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Feb. 28 2025

-0.16

-0.15

-0.15

Met

3.2

Nov. 30 2025

-0.12

-0.12

-0.16

Missed

-33.3

Aug. 31 2024

-0.11

-0.14

Missed

-27.3​

May. 31 2024

-0.08

-0.10

-0.13

Missed

-25.8

​​Feb. 29 2024

-0.10

-0.10

-0.06

Beat

40

Nov. 30 2023

-0.11

-0.11

-0.13

Missed

-18.2​

Aug. 31 2023

-0.17

-0.13

-0.12

Beat

11.1

May. 31 2023

-0.25

-0.25

-0.37

Missed

-48

This summary was machine generated July 8 at 11:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI